Skip to main content
. 2015 Feb 7;21(5):1580–1587. doi: 10.3748/wjg.v21.i5.1580

Table 2.

Main outcomes and complications

Stent type
P value
Uncovered (n = 38) Covered (n = 29)
Technical success 38 (100) 28 (96.6) 0.433
Clinical success 34 (89.5) 24 (82.8) 0.485
GOOSS score
Pre-stenting (0/1/2/3) 31/3/4/0 25/2/2/0 0.5841
Post-stenting (0/1/2/3) 4/10/18/61 5/11/10/32 0.1661
Causes of clinical failure 4 (10.5) 4 (13.8) 0.485
Poor expansion 2 (5.3) 0 (0.0) 0.502
Migration 0 (0.0) 2 (6.9) 0.184
Perforation 0 (0.0) 1 (3.4) 0.433
Peritoneal seeding 1 (2.7) 0 (0.0) 1.000
Septic shock 1 (2.7) 1 (3.4) 1.000
Complications 12 (31.6) 12 (41.4) 0.407
Migration 0 (0.0) 6 (20.7) 0.005
Tumor ingrowth 6 (15.8) 1 (3.4) 0.129
Perforation 0 (0.0) 2 (6.9) 0.184
Biliary obstruction 3 (7.9) 0 (0.0) 0.252
Stent collapse 0 (0.0) 3 (10.3) 0.076
Poor expansion 2 (5.3) 0 (0.0) 0.502
Food impact 1 (2.6) 0 (0.0) 1.000
Retreatment rate 12 (31.6) 10 (34.5) 0.802
Stenting 5 (13.2) 9 (31.0) 0.075
Operation 1 (2.6) 1 (3.4) 1.000
Removal of food materials 1 (2.6) 0 (0.0) 1.000
Ballooning 2 (5.3) 0 (0.0) 0.502
PTBD 3 (7.9) 0 (0.0) 0.252
30-d mortality 6 (15.8) 8 (27.6) 0.239
Median time interval to reintervention from initial intervention (d) 60 (14-251) 71 (2-147) 0.573
1

Linear by linear association;

2

The GOOSS score improved significantly after stent placement than those before stent placement (P < 0.001, Wilcoxon signed-rank test). Values are presented as number (%) or d (range). GOOSS: Gastric outlet obstruction scoring system = no oral intake, 0; liquid only, 1; soft solids, 2; low-residue or full diet; PTBD: Percutaneous biliary drainage.